FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W322732258> ?p ?o ?g. }

• W322732258 endingPage "1502" @default.
• W322732258 startingPage "1493" @default.
• W322732258 abstract "It has recently been shown that repeated large-volume paracentesis associated with intravenous albumin infusion is a rapid, effective, and safe therapy of ascites in cirrhosis. To investigate whether intravenous albumin infusion is necessary in the treatment of cirrhotics with large-volume paracentesis, 105 patients with tense ascites were randomly allocated into two groups. Fifty-two patients (group 1) were treated with paracentesis (4-6 L/day until disappearance of ascites) plus intravenous albumin infusion (40 g after each tap), and 53 (group 2) with paracentesis without albumin infusion. After disappearance of ascites, patients were discharged from the hospital with diuretics. Patients developing tense ascites during follow-up were treated according to their initial schedule. Paracentesis was effective in eliminating the ascites in 50 patients from group 1 and in 48 from group 2, with the duration of the hospital stay being approximately 11 days in both groups. Paracentesis plus intravenous albumin did not induce significant changes in standard renal function tests, plasma renin activity, and plasma aldosterone. In contrast, paracentesis without albumin was associated with a significant increase in blood urea nitrogen, a marked elevation in plasma renin activity and plasma aldosterone concentration, and a significant reduction in serum sodium concentration. One patient from group 1 and 11 from group 2 developed renal impairment or severe hyponatremia after treatment, or both (chi 2 = 9.19; p less than 0.01). The development of these complications could not be predicted by clinical and laboratory data before treatment. Although the probability of survival after entry into the study was similar in patients from both groups, a multivariate analysis identified the development of hyponatremia or renal impairment, or both, following the first paracentesis treatment and the occurrence of other complications during the first hospitalization (encephalopathy, gastrointestinal bleeding, and severe infection) as being the only independent predictors of mortality. These results indicate that intravenous albumin infusion is important in avoiding renal and electrolyte complications and activation of endogenous vasoactive systems in cirrhotics with ascites who are treated with repeated large-volume paracentesis. The development of such complications may impair survival in these patients." @default.
• W322732258 created "2016-06-24" @default.
• W322732258 creator A5012510507 @default.
• W322732258 creator A5029211589 @default.
• W322732258 creator A5030635582 @default.
• W322732258 creator A5048561028 @default.
• W322732258 creator A5052062860 @default.
• W322732258 creator A5056407115 @default.
• W322732258 creator A5070486020 @default.
• W322732258 creator A5074555301 @default.
• W322732258 creator A5079055724 @default.
• W322732258 creator A5079349599 @default.
• W322732258 creator A5080539242 @default.
• W322732258 creator A5080596662 @default.
• W322732258 creator A5084496662 @default.
• W322732258 creator A5086760814 @default.
• W322732258 date "1988-06-01" @default.
• W322732258 modified "2023-10-17" @default.
• W322732258 title "Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis" @default.
• W322732258 cites W1644737672 @default.
• W322732258 cites W177039186 @default.
• W322732258 cites W1964006707 @default.
• W322732258 cites W1972965645 @default.
• W322732258 cites W1987981002 @default.
• W322732258 cites W2007212031 @default.
• W322732258 cites W2014104984 @default.
• W322732258 cites W2016969540 @default.
• W322732258 cites W2017959995 @default.
• W322732258 cites W2019452049 @default.
• W322732258 cites W2022375793 @default.
• W322732258 cites W2033772754 @default.
• W322732258 cites W2051338237 @default.
• W322732258 cites W2056708771 @default.
• W322732258 cites W2145859088 @default.
• W322732258 cites W2146422707 @default.
• W322732258 cites W2341931351 @default.
• W322732258 cites W4241685356 @default.
• W322732258 doi "https://doi.org/10.1016/0016-5085(88)90691-9" @default.
• W322732258 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3360270" @default.
• W322732258 hasPublicationYear "1988" @default.
• W322732258 type Work @default.
• W322732258 sameAs 322732258 @default.
• W322732258 citedByCount "570" @default.
• W322732258 countsByYear W3227322582012 @default.
• W322732258 countsByYear W3227322582013 @default.
• W322732258 countsByYear W3227322582014 @default.
• W322732258 countsByYear W3227322582015 @default.
• W322732258 countsByYear W3227322582016 @default.
• W322732258 countsByYear W3227322582017 @default.
• W322732258 countsByYear W3227322582018 @default.
• W322732258 countsByYear W3227322582019 @default.
• W322732258 countsByYear W3227322582020 @default.
• W322732258 countsByYear W3227322582021 @default.
• W322732258 countsByYear W3227322582022 @default.
• W322732258 countsByYear W3227322582023 @default.
• W322732258 crossrefType "journal-article" @default.
• W322732258 hasAuthorship W322732258A5012510507 @default.
• W322732258 hasAuthorship W322732258A5029211589 @default.
• W322732258 hasAuthorship W322732258A5030635582 @default.
• W322732258 hasAuthorship W322732258A5048561028 @default.
• W322732258 hasAuthorship W322732258A5052062860 @default.
• W322732258 hasAuthorship W322732258A5056407115 @default.
• W322732258 hasAuthorship W322732258A5070486020 @default.
• W322732258 hasAuthorship W322732258A5074555301 @default.
• W322732258 hasAuthorship W322732258A5079055724 @default.
• W322732258 hasAuthorship W322732258A5079349599 @default.
• W322732258 hasAuthorship W322732258A5080539242 @default.
• W322732258 hasAuthorship W322732258A5080596662 @default.
• W322732258 hasAuthorship W322732258A5084496662 @default.
• W322732258 hasAuthorship W322732258A5086760814 @default.
• W322732258 hasConcept C126322002 @default.
• W322732258 hasConcept C138976137 @default.
• W322732258 hasConcept C141071460 @default.
• W322732258 hasConcept C159641895 @default.
• W322732258 hasConcept C198710026 @default.
• W322732258 hasConcept C2776125364 @default.
• W322732258 hasConcept C2776258039 @default.
• W322732258 hasConcept C2776703092 @default.
• W322732258 hasConcept C2777214474 @default.
• W322732258 hasConcept C2777364826 @default.
• W322732258 hasConcept C2780018836 @default.
• W322732258 hasConcept C2780026642 @default.
• W322732258 hasConcept C2780306776 @default.
• W322732258 hasConcept C2780496750 @default.
• W322732258 hasConcept C71924100 @default.
• W322732258 hasConcept C84393581 @default.
• W322732258 hasConcept C90924648 @default.
• W322732258 hasConceptScore W322732258C126322002 @default.
• W322732258 hasConceptScore W322732258C138976137 @default.
• W322732258 hasConceptScore W322732258C141071460 @default.
• W322732258 hasConceptScore W322732258C159641895 @default.
• W322732258 hasConceptScore W322732258C198710026 @default.
• W322732258 hasConceptScore W322732258C2776125364 @default.
• W322732258 hasConceptScore W322732258C2776258039 @default.
• W322732258 hasConceptScore W322732258C2776703092 @default.
• W322732258 hasConceptScore W322732258C2777214474 @default.
• W322732258 hasConceptScore W322732258C2777364826 @default.
• W322732258 hasConceptScore W322732258C2780018836 @default.

• next